FMP

FMP

Enter

INBX - Inhibrx Bi...

photo-url-https://images.financialmodelingprep.com/symbol/INBX.png

Inhibrx Biosciences, Inc.

INBX

NASDAQ

Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates includes INBRX-109, a tetravalent therapeutic candidate targeting death-receptor 5 that is in phase 2 clinical trial for the treatment of unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 that is in phase 2 clinical trial for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head and neck cancer, gastric (GIST) and gastroesophageal adenocarcinoma (GEA) cancer, renal cell carcinoma, and urothelial (transitional) cell carcinoma. The company was incorporated in 2024 and is based in La Jolla, California.

13.94 USD

-0.16 (-1.15%)

Build Up Free Cash Flow

Year

2021

2022

2023

2024

2025

2026

2027

2028

2029

2030

Revenue

607.64M

892.25M

1.06B

1.31B

1.43B

1.78B

2.22B

2.76B

3.44B

4.29B

Operating Cash Flow

29.18M

-54.96M

-9.98M

299.08M

320.56M

153.13M

190.78M

237.68M

296.12M

368.92M

Cap Ex

-3.19M

-13.06M

-23.82M

-7.34M

-14.92M

-20.82M

-25.94M

-32.31M

-40.26M

-50.16M

Free Cash Flow

25.98M

-68.02M

-33.8M

291.74M

305.64M

132.31M

164.84M

205.37M

255.86M

318.76M

Wacc

-

-

-

-

-

Pv Lfcf

-

-

-

-

-

Sum Pv Lfcf

-

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2024 © Financial Modeling Prep